TherapeuticsMD, Inc.
TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical royalty company that earns royalties from pharmaceutical partners commercializing women’s health products. In 2022, it licensed U.S. commercialization rights for IMVEXXY, BIJUVA and prescription prenatal vitamins to Mayne Pharma, and assigned Mayne its U.S. ANNOVERA… From the company’s description.
Over the twelve months to Jun 30, 2026, TherapeuticsMD, Inc. reported revenue of $3.27M, up 27.8% from a year earlier, and a net loss of $0.29M. Its operating margin was −120.9%, and operations generated $3.10M in cash. In fiscal 2025, it reported revenue of $3.02M, up 71.6% from fiscal 2024, and a net loss of $0.65M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What TherapeuticsMD, Inc. does
In the company’s own words
TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical royalty company that earns royalties from pharmaceutical partners commercializing women’s health products. In 2022, it licensed U.S. commercialization rights for IMVEXXY, BIJUVA and prescription prenatal vitamins to Mayne Pharma, and assigned Mayne its U.S. ANNOVERA rights; it also licenses IMVEXXY and BIJUVA to partners for markets outside the United States. IMVEXXY is an estradiol vaginal insert for menopausal vaginal pain, BIJUVA is an oral estradiol-and-progesterone capsule for menopausal hot flashes, and ANNOVERA is a reusable vaginal contraceptive system intended for up to 13 cycles. The prenatal vitamin lines include vitaMedMD and BocaGreenMD products. The company has three licensees and no reportable operating segments described in its business overview. Its royalty portfolio includes the IMVEXXY, BIJUVA, ANNOVERA, vitaMedMD and BocaGreenMD brands, while TherapeuticsMD also retains rights to its corporate name and marks. As of December 31, 2025, it employed one full-time employee. Its website is www.therapeuticsmd.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- BOCA RATON, FL
- Fiscal year end
- December
- CIK
- 25743
- SIC
- 2834
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns TherapeuticsMD, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · TherapeuticsMD, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do TherapeuticsMD, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of TherapeuticsMD, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in TherapeuticsMD, Inc.'s last four quarterly filings that the numbers alone won't show?”